or Try an Advanced Search...

    Immune Diseases Stocks List

    Symbol Grade Name % Change
    TLSA C Tiziana Life Sciences plc -2.05
    TRML C Tourmaline Bio, Inc. -4.88
    REGN F Regeneron Pharmaceuticals, Inc. -0.19
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Immunology Angiogenesis Antibodies Asthma Atherosclerosis Atopic Dermatitis Biopharmaceutical Bone Breakthrough Therapy Cancer Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disorders Human Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Immune Diseases stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 6.9
    IBB D iShares Nasdaq Biotechnology Index Fund 5.71
    IBBQ D Invesco Nasdaq Biotechnology ETF 5.67
    CANC D Tema Oncology ETF 5.25
    MNTL D Tema Neuroscience and Mental Health ETF 4.53
    View all Immune Diseases ETFs...
    Compare ETFs
    Compare BBH to CANC Compare BBH to IBBQ Compare IBBQ to MNTL

        Immune Diseases Stocks Recent News

        Date Stock Title
        Nov 21 TLSA Elon Musk Says Amazon Founder Jeff Bezos Urged Tesla, SpaceX Investors To Dump Stakes, Predicting Trump's Loss
        Nov 20 TLSA Tiziana Life Sciences Secures ALS Trial Funding
        Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)
        Nov 19 REGN Regeneron: The Biotech Stock To Buy Now
        Nov 19 REGN Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
        Nov 19 TLSA Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
        Nov 18 REGN FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
        Nov 18 TLSA Cathie Wood Redirects Elon Musk's DOGE Focus Toward Nuclear Energy Amid Regulatory Challenges: Here's How Oklo, Cameco, Centrus Energy And Other Stocks Performed
        Nov 15 REGN FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
        Nov 15 REGN Regeneron, Sanofi say resubmitted application to expand Dupixent label accepted in U.S.
        Nov 15 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Immunology Angiogenesis Antibodies Asthma Atherosclerosis Atopic Dermatitis Biopharmaceutical Bone Breakthrough Therapy Cancer Cardiovascular Disease Cartilage Cholesterol Clinical Development Clinical Research Colorectal Cancer Dermatitis Disorders Human Diseases
        Immune Diseases

        Immune diseases are conditions that occur when the body's immune system malfunctions and attacks healthy cells, tissues, and organs. Examples of immune diseases include autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.

        Browse All Tags